We further showed that knockdown of endogenous Gal-9 or addition of a Gal-9 MAb in the culture medium at an early infection stage impaired the proliferation and colony formation of EBV-infected B cells (before 14 days) and impeded the acute and latent infection. Here, LGALS9 is linked to disease arising from reactivation of latent virus.